Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | phosphorylase, glycogen, liver | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0056 | 0.0343 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.013 | 0.4301 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0237 | 1 | 1 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.013 | 0.4301 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.013 | 0.4301 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0237 | 1 | 1 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0056 | 0.0343 | 0.5 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.013 | 0.4301 | 0.4301 |
Giardia lamblia | Glycogen phosphorylase | 0.013 | 0.4301 | 0.5 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.013 | 0.4301 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.013 | 0.4301 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 1 | 1 |
Brugia malayi | carbohydrate phosphorylase | 0.013 | 0.4301 | 0.4301 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.013 | 0.4301 | 1 |
Chlamydia trachomatis | glycogen phosphorylase | 0.013 | 0.4301 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.013 | 0.4301 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.063 uM | Inhibition of human hepatic recombinant glycogen phosphorylase by multienzyme coupled assay | ChEMBL. | 17095214 |
IC50 (binding) | = 0.063 uM | Inhibition of human hepatic recombinant glycogen phosphorylase by multienzyme coupled assay | ChEMBL. | 17095214 |
IC50 (functional) | = 2.7 uM | Inhibition of glucose output in glucagon challenged primary rat hepatocytes | ChEMBL. | 17095214 |
Papp (ADMET) | = 0.3 10^-6 cm/s | Permeability from apical to basolateral side of the Caco2 cell membrane | ChEMBL. | 17095214 |
Papp (ADMET) | = 0.3 10^-6 cm/s | Permeability from apical to basolateral side of the Caco2 cell membrane | ChEMBL. | 17095214 |
Papp (ADMET) | = 11 10^-6 cm/s | Permeability from basolateral to apical side of the Caco2 cell membrane | ChEMBL. | 17095214 |
Papp (ADMET) | = 11 10^-6 cm/s | Permeability from basolateral to apical side of the Caco2 cell membrane | ChEMBL. | 17095214 |
PPB (ADMET) | = 0.12 % | Plasma protein binding | ChEMBL. | 17095214 |
Solubility | = 595 uM | Solubility in water | ChEMBL. | 17095214 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.